Guidance Revises Review Standard for Type II DMFs Linked to ANDAs By Sam | March 8, 2016 CDER is tightening up its protocols for companies submitting data about active pharmaceutical ingredients used in generic drugs. Source: Generic Line Posted in Generic Line